Template:ID-Parasitic meningitis: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) mNo edit summary |
Gerald Chi- (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
* Protozoal meningitis | * Protozoal meningitis | ||
:* Pathogen-directed antimicrobial therapy | :* Pathogen-directed antimicrobial therapy | ||
::* '''Naegleria fowleri (primary amebic meningoencephalitis)''' | ::* '''Naegleria fowleri (primary amebic meningoencephalitis)'''<ref>{{Cite journal| doi = 10.1542/peds.2014-2292| issn = 1098-4275| volume = 135| issue = 3| pages = –744-748| last1 = Linam| first1 = W. Matthew| last2 = Ahmed| first2 = Mubbasheer| last3 = Cope| first3 = Jennifer R.| last4 = Chu| first4 = Craig| last5 = Visvesvara| first5 = Govinda S.| last6 = da Silva| first6 = Alexandre J.| last7 = Qvarnstrom| first7 = Yvonne| last8 = Green| first8 = Jerril| title = Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis| journal = Pediatrics| date = 2015-03| pmid = 25667249}}</ref><ref>{{Cite journal| issn = 0188-4409| volume = 36| issue = 1| pages = 83–86| last1 = Vargas-Zepeda| first1 = Jesús| last2 = Gómez-Alcalá| first2 = Alejandro V.| last3 = Vásquez-Morales| first3 = José Alfonso| last4 = Licea-Amaya| first4 = Leonardo| last5 = De Jonckheere| first5 = Johan F.| last6 = Lares-Villa| first6 = Fernando| title = Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin| journal = Archives of Medical Research| date = 2005-02| pmid = 15900627}}</ref> | ||
:::* Preferred regimen: [[Amphotericin B]] 1.5 mg/kg/day IV q12h for 3 days, followed by [[Amphotericin B]] 1 mg/kg/day IV for 6 days {{and}} [[Amphotericin B]] 1.5 mg/kg/day intrathecal for 2 days, followed by [[Amphotericin B]] 1 mg/kg/day intrathecal qod for 8 days | :::* Preferred regimen: [[Amphotericin B]] 1.5 mg/kg/day IV q12h for 3 days, followed by [[Amphotericin B]] 1 mg/kg/day IV for 6 days {{and}} [[Amphotericin B]] 1.5 mg/kg/day intrathecal for 2 days, followed by [[Amphotericin B]] 1 mg/kg/day intrathecal qod for 8 days | ||
:::* Alternative regimen: [[Amphotericin B]] 0.25–1 mg/kg/day IV q24h for 2 weeks {{and}} [[Fluconazole]] 10 mg/kg IV q24h for 30 days {{and}} [[Rifampicin]] 10 mg/kg PO qd for 30 days {{and}} [[Dexamethasone]] 0.15 mg/kg IV q6h for 30 days | :::* Alternative regimen: [[Amphotericin B]] 0.25–1 mg/kg/day IV q24h for 2 weeks {{and}} [[Fluconazole]] 10 mg/kg IV q24h for 30 days {{and}} [[Rifampicin]] 10 mg/kg PO qd for 30 days {{and}} [[Dexamethasone]] 0.15 mg/kg IV q6h for 30 days | ||
Revision as of 23:31, 19 June 2015
- Protozoal meningitis
- Pathogen-directed antimicrobial therapy
-
- Preferred regimen: Amphotericin B 1.5 mg/kg/day IV q12h for 3 days, followed by Amphotericin B 1 mg/kg/day IV for 6 days AND Amphotericin B 1.5 mg/kg/day intrathecal for 2 days, followed by Amphotericin B 1 mg/kg/day intrathecal qod for 8 days
- Alternative regimen: Amphotericin B 0.25–1 mg/kg/day IV q24h for 2 weeks AND Fluconazole 10 mg/kg IV q24h for 30 days AND Rifampicin 10 mg/kg PO qd for 30 days AND Dexamethasone 0.15 mg/kg IV q6h for 30 days
- ↑ Linam, W. Matthew; Ahmed, Mubbasheer; Cope, Jennifer R.; Chu, Craig; Visvesvara, Govinda S.; da Silva, Alexandre J.; Qvarnstrom, Yvonne; Green, Jerril (2015-03). "Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis". Pediatrics. 135 (3): –744-748. doi:10.1542/peds.2014-2292. ISSN 1098-4275. PMID 25667249. Check date values in:
|date=(help) - ↑ Vargas-Zepeda, Jesús; Gómez-Alcalá, Alejandro V.; Vásquez-Morales, José Alfonso; Licea-Amaya, Leonardo; De Jonckheere, Johan F.; Lares-Villa, Fernando (2005-02). "Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin". Archives of Medical Research. 36 (1): 83–86. ISSN 0188-4409. PMID 15900627. Check date values in:
|date=(help)